Jonathan Kimmelman
Biography:
Jonathan Kimmelman's research group, STREAM, studies the ethical, policy, and scientific dimensions of drug development and clinical trials. Kimmelman also directs McGill's Biomedical Ethics Unit, and has served in numerous policy committees, including four tours of duty on U.S. National Academy of Medicine committees.
Publications
Website
Areas of expertise:
Meta-research, clinical trials, research ethics, drug development, pharmaceutical policy, medical decision-making, risk
Group:
Associate Members
Research areas:
Clinical Epidemiology and Informatics
Health Services and Health Policy
Areas of interest:
Keywords: cancer, neurology, cell therapy, gene therapy, phase 1 trials